Search Results

There are 17840 results for: content related to: Erythropoietin receptor expression is concordant with erythropoietin but not with common β chain expression in the rat brain throughout the life span

  1. You have free access to this content
    Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response

    Journal of Internal Medicine

    Volume 264, Issue 5, November 2008, Pages: 405–432, M. Brines and A. Cerami

    Version of Record online : 8 OCT 2008, DOI: 10.1111/j.1365-2796.2008.02024.x

  2. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase

    Journal of Cellular Physiology

    Volume 226, Issue 12, December 2011, Pages: 3330–3339, Kuo-Hui Su, Song-Kun Shyue, Yu Ru Kou, Li-Chieh Ching, An-Na Chiang, Yuan-Bin Yu, Chien-Yu Chen, Ching-Chian Pan and Tzong-Shyuan Lee

    Version of Record online : 23 SEP 2011, DOI: 10.1002/jcp.22678

  3. Erythropoietin

    Standard Article

    Comprehensive Physiology

    Roland H. Wenger and Armin Kurtz

    Published Online : 1 OCT 2011, DOI: 10.1002/cphy.c100075

  4. You have free access to this content
    The non-haematopoietic biological effects of erythropoietin

    British Journal of Haematology

    Volume 141, Issue 1, April 2008, Pages: 14–31, Murat O. Arcasoy

    Version of Record online : 6 MAR 2008, DOI: 10.1111/j.1365-2141.2008.07014.x

  5. You have free access to this content
    Identification of a cytoplasmic motif in the erythropoietin receptor required for receptor internalization

    FEBS Letters

    Volume 427, Issue 2, May 08, 1998, Pages: 164–170, Iris Levin, Jacob Cohen, Lia Supino-Rosin, Akihiko Yoshimura, Stephanie S Watowich and Drorit Neumann

    Version of Record online : 18 DEC 1998, DOI: 10.1016/S0014-5793(98)00414-1

  6. You have free access to this content
    Amino acid residues 268–276 of the erythropoietin receptor contain an endocytosis motif and are required for erythropoietin-mediated proliferation

    FEBS Letters

    Volume 518, Issue 1-3, May 08, 2002, Pages: 189–194, Galit Flint-Ashtamker, Ronit Eisen-Lev, Jacob Cohen, Lily Jun-shen Huang and Drorit Neumann

    Version of Record online : 17 APR 2002, DOI: 10.1016/S0014-5793(02)02691-1

  7. AMP-activated protein kinase mediates erythropoietin-induced activation of endothelial nitric oxide synthase

    Journal of Cellular Physiology

    Volume 227, Issue 8, August 2012, Pages: 3053–3062, Kuo-Hui Su, Yuan-Bin Yu, Hsin-Han Hou, Jin-Feng Zhao, Yu Ru Kou, Li-Ching Cheng, Song-Kun Shyue and Tzong-Shyuan Lee

    Version of Record online : 23 APR 2012, DOI: 10.1002/jcp.23052

  8. You have free access to this content
    Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events

    Transplant International

    Volume 27, Issue 3, March 2014, Pages: 241–248, Willem G. van Rijt, Harry van Goor, Rutger J. Ploeg and Henri G. D. Leuvenink

    Version of Record online : 22 AUG 2013, DOI: 10.1111/tri.12174

  9. Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat

    European Journal of Neuroscience

    Volume 26, Issue 1, July 2007, Pages: 90–100, V. R. King, S. A. Averill, D. Hewazy, J. V. Priestley, Lars Torup and A. T. Michael-Titus

    Version of Record online : 3 JUL 2007, DOI: 10.1111/j.1460-9568.2007.05635.x

  10. The GM–CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling

    Immunological Reviews

    Volume 250, Issue 1, November 2012, Pages: 277–302, Sophie E. Broughton, Urmi Dhagat, Timothy R. Hercus, Tracy L. Nero, Michele A. Grimbaldeston, Claudine S. Bonder, Angel F. Lopez and Michael W. Parker

    Version of Record online : 10 OCT 2012, DOI: 10.1111/j.1600-065X.2012.01164.x

  11. You have free access to this content
    A cytosolic domain of the erythropoietin receptor contributes to endoplasmic reticulum-associated degradation

    European Journal of Biochemistry

    Volume 263, Issue 2, July (II) 1999, Pages: 410–419, Lia Supino-Rosin, Akihiko Yoshimura, Hanna Altaratz and Drorit Neumann

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1432-1327.1999.00516.x

  12. Prolonged erythropoietin treatment does not impact gene expression in human skeletal muscle

    Muscle & Nerve

    Volume 51, Issue 4, April 2015, Pages: 554–561, Britt Christensen, Birgitte Nellemann, Kasper Thorsen, Morten Muhlig Nielsen, Steen B. Pedersen, Marie Juul Ornstrup, Jens Otto L. JØrgensen and Niels Jessen

    Version of Record online : 25 FEB 2015, DOI: 10.1002/mus.24355

  13. Erythropoietin Receptor Is Expressed on Human Peripheral Blood T and B Lymphocytes and Monocytes and Is Modulated by Recombinant Human Erythropoietin Treatment

    Artificial Organs

    Volume 34, Issue 8, August 2010, Pages: 654–662, Katarzyna A. Lisowska, Alicja Dębska-Ślizień, Ewa Bryl, Bolesław Rutkowski and Jacek M. Witkowski

    Version of Record online : 31 MAY 2010, DOI: 10.1111/j.1525-1594.2009.00948.x

  14. You have free access to this content
    Cochrane review: Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 5, Issue 1, March 2010, Pages: 151–238, Arne Ohlsson and Sanjay M Aher

    Version of Record online : 18 JUN 2010, DOI: 10.1002/ebch.521

  15. You have free access to this content
    Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants

    Intervention Review

    The Cochrane Library

    Arne Ohlsson and Sanjay M Aher

    Published Online : 26 APR 2014, DOI: 10.1002/14651858.CD004863.pub4

  16. Emerging technologies in the delivery of erythropoietin for therapeutics

    Medicinal Research Reviews

    Volume 31, Issue 2, March 2011, Pages: 284–309, Ainhoa Murua, Gorka Orive, Rosa Ma Hernández and José Luis Pedraz

    Version of Record online : 4 DEC 2009, DOI: 10.1002/med.20184

  17. You have free access to this content
    Erythropoietin after a century of research: younger than ever

    European Journal of Haematology

    Volume 78, Issue 3, March 2007, Pages: 183–205, Wolfgang Jelkmann

    Version of Record online : 23 JAN 2007, DOI: 10.1111/j.1600-0609.2007.00818.x

  18. De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival

    Neuropathology and Applied Neurobiology

    Volume 33, Issue 3, June 2007, Pages: 299–307, M. Mittelbronn, D. Capper, B. Bunz, K. Dietz, B. Goeppert, R. Ajaaj, G. Tabatabai, F. Stubenvoll, H. Schlaszus, A. S. Merseburger, R. Becker, D. Freudenstein, W. Wick, M. Weller, R. Meyermann and P. Simon

    Version of Record online : 22 JAN 2007, DOI: 10.1111/j.1365-2990.2006.00820.x

  19. You have full text access to this OnlineOpen article
    EPO-receptor is present in mouse C2C12 and human primary skeletal muscle cells but EPO does not influence myogenesis

    Physiological Reports

    Volume 2, Issue 3, March 2014, Séverine Lamon, Evelyn Zacharewicz, Andrew N. Stephens and Aaron P. Russell

    Version of Record online : 26 MAR 2014, DOI: 10.1002/phy2.256

  20. You have free access to this content
    Organ-Protective and Immunomodulatory Effects of Erythropoietin – An Update on Recent Clinical Trials

    Basic & Clinical Pharmacology & Toxicology

    Volume 110, Issue 2, February 2012, Pages: 113–121, Christoffer Sølling

    Version of Record online : 9 NOV 2011, DOI: 10.1111/j.1742-7843.2011.00820.x